IMPEDIMED FPO [IPD] (IPD.AX)
Makes handheld devices that measure body fluid and tissue composition for medical diagnosis
0.00+0.00%Healthcare
StockGlow Score
Neutral
BearishBullish
1 year ago-91.5%
The outlook
IPD.AX trades near its 52-week lows with analyst consensus strongly bullish and an average price target implying 431% upside from current levels. The stock sits below both its 50- and 200-day moving averages, reflecting a weak recent trend despite the positive analyst view.
What’s behind the score
Analyst consensusStrong Buy — 1.3 avg of 4 analysts
Price trendBelow its 50- & 200-day averages
52-week range2% of the way from its 52-week low to high
Price targetAvg target +431% vs current price
Analyst price target
~12-month · 4 analysts0.02average target+431.3% vs now
Now 0.00
Low 0.01High 0.04
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
—
52-wk high
0.06
52-wk low
0.00
50-day avg
0.01
200-day avg
0.02
Trailing P/E
—